NIOX Group Plc

AIM-NIOX
London Stock Exchange AIM
Healthcare Medical - Equipment & Services
Global Rank
#16116
Country Rank
#404
Market Cap
386.91 M
Price
92.26
Change (%)
0.43%
Volume
104,120

NIOX Group Plc's latest marketcap:

386.91 M

As of 07/28/2025, NIOX Group Plc's market capitalization has reached $386.91 M. According to our data, NIOX Group Plc is the 16116th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 386.91 M
Revenue (ttm) 56.13 M
Net Income (ttm) 4.97 M
Shares Out 417.56 M
EPS (ttm) 0.01
Forward PE 25.96
Ex-Dividend Date 05/15/2025
Earnings Date 09/30/2025
Market Cap Chart
Data Updated: 07/28/2025

NIOX Group Plc's yearly market capitalization.

NIOX Group Plc has seen its market value drop from £528.01 M to £288.12 M since 2014, representing a total decrease of 45.43% and an annual compound decline rate (CAGR) of 5.57%.
Date Market Cap(£) Market Cap(USD) Change (%) Global Rank
07/28/2025 £288.12 M $386.91 M 14.91% 16116
12/31/2024 £250.73 M $313.68 M -11.04% 16128
12/29/2023 £281.86 M $358.81 M 84.1% 15254
12/30/2022 £153.1 M $185.15 M -9.72% 18481
12/31/2021 £169.58 M $229.23 M 51.54% 18054
12/31/2020 £111.91 M $152.98 M 57.21% 18177
12/31/2019 £71.18 M $94.39 M -58.42% 18438
12/31/2018 £171.21 M $218.29 M -50.59% 13501
12/29/2017 £346.53 M $467.84 M 29.45% 10761
12/30/2016 £267.69 M $330.49 M -70.57% 10868

Company Profile

About NIOX Group Plc

NIOX Group Plc specializes in the design, development, and commercialization of advanced medical devices focused on asthma diagnosis, monitoring, and management. The company operates globally, providing innovative solutions to improve respiratory care.

Key Products

  • NIOX VERO: A non-invasive, point-of-care system featuring a portable device and a range of consumables, including sensors, disposable mouthpieces, and breathing handles. This system measures Fractional Exhaled Nitric Oxide (FeNO) levels in patients.

Company Background

Formerly known as Circassia Group Plc, the company rebranded to NIOX Group Plc in September 2022. Founded in 2006, NIOX Group Plc is headquartered in Oxford, United Kingdom.

Frequently Asked Questions

  • What is NIOX Group Plc's (AIM-NIOX) current market cap?
    As of 07/28/2025, NIOX Group Plc (including the parent company, if applicable) has an estimated market capitalization of $386.91 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • NIOX Group Plc global market capitalization ranking is approximately 16116 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.